comparemela.com

Latest Breaking News On - மருத்துவ ஆராய்ச்சியாளர் - Page 4 : comparemela.com

Dr. Ernst Von Schwarz Explains COVID-19 Infection and Deaths Even After Vaccination

Dr. Ernst Von Schwarz Explains COVID-19 Infection and Deaths Even After Vaccination
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Russia
Israel
Argentina
Russian
Israeli
Alber-elbaz
Pfizer
President-fernandez
Medical-researcher
ரஷ்யா
இஸ்ரேல்
அர்ஜெண்டினா

We're on the hunt for novel ways to assess the risk of type 2 diabetes

We're on the hunt for novel ways to assess the risk of type 2 diabetes
downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.

South-africa
Cape-peninsula
Western-cape
Cecil-jack-weale
Cape-peninsula-university-of-technology
International-diabetes-federation
Jack-weale
Assistant-lecturer
Medical-researcher
Cape-peninsula-university
Creative-commons
Weekly-newsletter

Combination of drugs promising for brain tumor treatment

Combination of drugs promising for brain tumor treatment Results from a phase 1 clinical trial suggests that the immunotherapy drug and new precision drug work together to attack the tumor and reduce the cancer in some patients. By iStock Story at a glance Researchers are testing out a combination of two drugs as a treatment for an aggressive type of brain cancer called glioblastoma. These drugs target the immune system and allow it to target the tumor. A phase 1 clinical trial shows promising results from two patients. Glioblastoma is a type of cancer that can form in the brain or spinal cord. The drugs used in the clinical trial are atezolizumab, an immunotherapy drug, and ipatasertib, a new precision drug that “may be able to uncloak tumours to the immune system,” according to a statement from the Institute of Cancer Research, London.

United-states
London
City-of
United-kingdom
America
Juanita-lopez
Institute-of-cancer-research
Food-drug-administration
Cancer-research
Clinical-researcher
Add-changing-america
Drug-administration

April 2021 - PharmaTimes

PharmaTimes - April 2021 With the anchor now securely lodged in 2021, what’s on the horizon for the life sciences industry and for healthcare in the UK? Certainly for healthcare, the tide seems to be turning again. As the team at Wilmington outlines on page 16, the government is proposing some of the most important reforms for health and social care in nearly a decade, which plan a shift away from competition towards collaborative working, but also seek to hand more power to ministers to intervene in decisions on healthcare services. Elsewhere, Dr Kath MacKay looks into three areas for development in the UK life sciences sector in the years ahead: the end of malaria, the commercial appeal of science and quantum computing and health data (p18), while on page 22 Gilead’s Frances Luff emphasises the importance of the NICE methods review, and the opportunity it presents for enhancing how the value of innovative therapies is measured in today’s landscape.

United-kingdom
Kath-mackay
Geraldine-reil
Frances-luff
Samantha-dawson
Patient-partnership-index
Pharmatimes-international-clinical-researcher-of-the-year
Times-marketer
Communications-awards
Sales-awards
Pharmatimes-international-clinical-researcher
Clinical-researcher

Finalists from last year's CROY share their highlights

Finalists from last year’s CROY share their highlights 16th March 2021 Clinical Researcher of the Year – The Americas finalists reveal their positive experiences with the 2020 competition. In a first for the competition, last year’s finals days and awards ceremony were conducted virtually with our finalists presenting their response to the challenge brief via video link. Despite the slight change in direction, our finalists were happy as ever to offer insight into why they enjoyed the event. Rachel Palumbo of PRA and Winner of the 2020 Start Up category praised PharmaTimes on the innovation to adapt the competition to the turbulent climate, she said,

Joella-kitrell
Rachel-palumbo
Syneos-health
Company-team
Clinical-researcher
Clinical-research
Pharmatimes-clinical-researcher-of-the-year-americas
ரேச்சல்-பலம்போ
நிறுவனம்-அணி
மருத்துவ-ஆராய்ச்சியாளர்
மருத்துவ-ஆராய்ச்சி

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.